It exerts its effects through two distinct receptors, type 1 (AT1) and type 2 (AT2) receptors, with AT1 receptors being responsible for promoting vasoconstriction, the release of vasopressin and aldosterone, stimulating cellular growth and migration, and participating in complex pro-inflammatory processes such as atherosclerosis and vascular aging [17, 18]. This evidence concerns the gene AGTR1 and atherosclerosis.